MPO and vasculitis: These findings imply that in patients with EGPA who are classified based on the 2022 ACR/EULAR classification criteria [10], MPO-ANCA positivity may be more closely associated with disease burden and health-related quality of life than with a dichotomous pattern of vasculitis- or eosinophil-specific manifestations.